Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 122,710 | 98,509 | 110,568 | 102,688 | 99,582 |
| Cost of Goods | 15,405 | 12,520 | 15,809 | 14,167 | 12,045 |
| Gross Profit | 107,305 | 85,989 | 94,759 | 88,521 | 87,537 |
| Operating Expenses | 53,464 | 59,383 | 53,876 | 125,876 | 40,883 |
| Operating Income | 54,246 | 27,126 | 41,692 | -37,188 | 46,699 |
| Other Income | 1,542 | 1,963 | 5,015 | -833 | 1,813 |
| Pre-tax Income | 55,788 | 29,089 | 46,707 | -38,021 | 48,512 |
| Income Tax | 14,994 | 5,814 | 11,863 | -7,257 | 10,750 |
| Net Income Continuous | 40,794 | 23,275 | 34,844 | -30,764 | 37,762 |
| Net Income | $40,794 | $23,275 | $34,844 | $-30,764 | $37,762 |
| EPS Basic Total Ops | 0.35 | 0.20 | 0.32 | -0.29 | 0.36 |
| EPS Basic Continuous Ops | 0.35 | 0.20 | 0.33 | -0.29 | 0.36 |
| EPS Diluted Total Ops | 0.33 | 0.19 | 0.33 | -0.29 | 0.33 |
| EPS Diluted Continuous Ops | 0.33 | 0.19 | 0.32 | -0.29 | 0.33 |
| EPS Diluted Before Non-Recurring Items | 0.52 | 0.31 | 0.49 | N/A | N/A |
| EBITDA(a) | $63,681 | $36,556 | $50,835 | $-28,620 | $55,269 |